Electronic Submission of Expedited Safety Reports From IND-Exempt BA/BE Studies Guidance for Industry

[FDA]

This draft guidance will assist prospective ANDA applicants in submitting expedited safety reports of serious adverse events (SAEs) from certain bioavailability (BA)/bioequivalence (BE) studies in electronic format.


Baca selengkapnya di : http://www.fda.gov...